vs

Side-by-side financial comparison of QUINSTREET, INC (QNST) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

QUINSTREET, INC is the larger business by last-quarter revenue ($287.8M vs $151.7M, roughly 1.9× Tarsus Pharmaceuticals, Inc.). QUINSTREET, INC runs the higher net margin — 17.4% vs -5.5%, a 23.0% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 1.9%). QUINSTREET, INC produced more free cash flow last quarter ($20.7M vs $13.0M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 53.2%).

QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

QNST vs TARS — Head-to-Head

Bigger by revenue
QNST
QNST
1.9× larger
QNST
$287.8M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+126.5% gap
TARS
128.4%
1.9%
QNST
Higher net margin
QNST
QNST
23.0% more per $
QNST
17.4%
-5.5%
TARS
More free cash flow
QNST
QNST
$7.8M more FCF
QNST
$20.7M
$13.0M
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
53.2%
QNST

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
QNST
QNST
TARS
TARS
Revenue
$287.8M
$151.7M
Net Profit
$50.2M
$-8.4M
Gross Margin
9.6%
Operating Margin
0.4%
-5.3%
Net Margin
17.4%
-5.5%
Revenue YoY
1.9%
128.4%
Net Profit YoY
3342.5%
63.8%
EPS (diluted)
$0.87
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QNST
QNST
TARS
TARS
Q4 25
$287.8M
$151.7M
Q3 25
$285.9M
$118.7M
Q2 25
$102.7M
Q1 25
$269.8M
$78.3M
Q4 24
$282.6M
$66.4M
Q3 24
$279.2M
$48.1M
Q2 24
$198.3M
$40.8M
Q1 24
$168.6M
$27.6M
Net Profit
QNST
QNST
TARS
TARS
Q4 25
$50.2M
$-8.4M
Q3 25
$4.5M
$-12.6M
Q2 25
$-20.3M
Q1 25
$4.4M
$-25.1M
Q4 24
$-1.5M
$-23.1M
Q3 24
$-1.4M
$-23.4M
Q2 24
$-2.2M
$-33.3M
Q1 24
$-7.0M
$-35.7M
Gross Margin
QNST
QNST
TARS
TARS
Q4 25
9.6%
Q3 25
9.4%
Q2 25
Q1 25
10.3%
Q4 24
9.5%
Q3 24
10.2%
Q2 24
8.8%
Q1 24
8.5%
Operating Margin
QNST
QNST
TARS
TARS
Q4 25
0.4%
-5.3%
Q3 25
1.7%
-12.2%
Q2 25
-21.6%
Q1 25
1.8%
-33.5%
Q4 24
-0.5%
-36.8%
Q3 24
-0.4%
-52.3%
Q2 24
-0.7%
-81.6%
Q1 24
-3.2%
-136.5%
Net Margin
QNST
QNST
TARS
TARS
Q4 25
17.4%
-5.5%
Q3 25
1.6%
-10.6%
Q2 25
-19.8%
Q1 25
1.6%
-32.1%
Q4 24
-0.5%
-34.8%
Q3 24
-0.5%
-48.7%
Q2 24
-1.1%
-81.6%
Q1 24
-4.2%
-129.4%
EPS (diluted)
QNST
QNST
TARS
TARS
Q4 25
$0.87
$-0.17
Q3 25
$0.08
$-0.30
Q2 25
$-0.48
Q1 25
$0.08
$-0.64
Q4 24
$-0.03
$-0.57
Q3 24
$-0.02
$-0.61
Q2 24
$-0.04
$-0.88
Q1 24
$-0.13
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QNST
QNST
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$107.0M
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$294.4M
$343.4M
Total Assets
$493.0M
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QNST
QNST
TARS
TARS
Q4 25
$107.0M
$417.3M
Q3 25
$101.3M
$401.8M
Q2 25
$381.1M
Q1 25
$81.8M
$407.9M
Q4 24
$57.8M
$291.4M
Q3 24
$25.0M
$317.0M
Q2 24
$50.5M
$323.6M
Q1 24
$39.6M
$298.5M
Total Debt
QNST
QNST
TARS
TARS
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Q1 24
$29.9M
Stockholders' Equity
QNST
QNST
TARS
TARS
Q4 25
$294.4M
$343.4M
Q3 25
$246.7M
$335.1M
Q2 25
$332.6M
Q1 25
$235.5M
$342.5M
Q4 24
$224.3M
$224.5M
Q3 24
$219.8M
$237.5M
Q2 24
$216.8M
$252.2M
Q1 24
$215.0M
$275.2M
Total Assets
QNST
QNST
TARS
TARS
Q4 25
$493.0M
$562.2M
Q3 25
$442.6M
$534.6M
Q2 25
$495.0M
Q1 25
$417.2M
$500.8M
Q4 24
$409.6M
$377.0M
Q3 24
$401.2M
$376.3M
Q2 24
$368.5M
$376.8M
Q1 24
$349.3M
$349.3M
Debt / Equity
QNST
QNST
TARS
TARS
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QNST
QNST
TARS
TARS
Operating Cash FlowLast quarter
$21.6M
$19.3M
Free Cash FlowOCF − Capex
$20.7M
$13.0M
FCF MarginFCF / Revenue
7.2%
8.6%
Capex IntensityCapex / Revenue
0.3%
4.2%
Cash ConversionOCF / Net Profit
0.43×
TTM Free Cash FlowTrailing 4 quarters
$106.9M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QNST
QNST
TARS
TARS
Q4 25
$21.6M
$19.3M
Q3 25
$19.6M
$18.3M
Q2 25
$-29.4M
Q1 25
$30.1M
$-20.7M
Q4 24
$38.7M
$-22.2M
Q3 24
$-13.7M
$-8.7M
Q2 24
$16.6M
$-14.4M
Q1 24
$4.1M
$-37.8M
Free Cash Flow
QNST
QNST
TARS
TARS
Q4 25
$20.7M
$13.0M
Q3 25
$18.4M
$16.3M
Q2 25
$-30.4M
Q1 25
$29.5M
$-21.2M
Q4 24
$38.2M
$-22.3M
Q3 24
$-14.1M
$-8.9M
Q2 24
$15.4M
$-15.4M
Q1 24
$2.9M
$-38.0M
FCF Margin
QNST
QNST
TARS
TARS
Q4 25
7.2%
8.6%
Q3 25
6.4%
13.8%
Q2 25
-29.6%
Q1 25
10.9%
-27.1%
Q4 24
13.5%
-33.5%
Q3 24
-5.1%
-18.6%
Q2 24
7.8%
-37.8%
Q1 24
1.7%
-137.5%
Capex Intensity
QNST
QNST
TARS
TARS
Q4 25
0.3%
4.2%
Q3 25
0.4%
1.6%
Q2 25
1.0%
Q1 25
0.2%
0.8%
Q4 24
0.2%
0.1%
Q3 24
0.2%
0.6%
Q2 24
0.6%
2.5%
Q1 24
0.7%
0.6%
Cash Conversion
QNST
QNST
TARS
TARS
Q4 25
0.43×
Q3 25
4.32×
Q2 25
Q1 25
6.82×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

QNST
QNST

Financial Service$216.8M75%
Home Services And Other Revenue$71.0M25%

TARS
TARS

Segment breakdown not available.

Related Comparisons